nejm semaglutide heart failure on X: "Read the full results of the STEP-HFpEF trial, presented at #ESCCongress: Original Article: in Patients with and Obesity https://t.co/a3ovagJquz Editorial: Heart Failure with Preserved Ejection Fraction — SELECT Trial

Its also FDA-approved for weight loss and management in pediatric patients aged 12 and older with obesity

It is very important to carefully follow any instructions from your health care team about: Under certain conditions, too much metformin can cause lactic acidosis

As the central fat depots are metabolized, a relative redistribution of adipose tissue from visceral to subcutaneous regions may occur, at least under experimental conditions

10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure

To be eligible for Wegovy, our clinicians will review your consultation to ensure it is safe for you to use